Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
9.88
0.12 (1.23%)
At close: May 01, 2025, 3:59 PM
9.87
-0.05%
After-hours: May 01, 2025, 05:48 PM EDT
Stoke Therapeutics Revenue
Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending December 31, 2024, Stoke Therapeutics generated $22.61M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
534.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 36.55M | +316.34% |
| Dec 31, 2023 | 8.78M | -29.22% |
| Dec 31, 2022 | 12.4M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |